Cachofeiro V, Schiffrin E L, Cantin M, Garcia R
Laboratory of Experimental Hypertension and Vasoactive Peptides, Clinical Research Institute of Montreal, Quebec, Canada.
Cardiovasc Res. 1990 Oct;24(10):843-50. doi: 10.1093/cvr/24.10.843.
The aim was to study glomerular and vascular atrial natriuretic factor (ANF) receptors and their relationship with the post-receptor effects of the peptide in experimental heart failure.
Binding sites ANF were studied in renal glomerular and mesenteric artery membranes. The natriuretic and relaxing effects of ANF were evaluated in the intact animal and in noradrenaline precontracted aortic strips respectively. Plasma and tissue ANF levels were also assessed.
The study was performed on cardiomyopathic (UM-X7.1) hamsters (n = 15) with a moderate degree of heart failure. Age matched Golden Syriam hamsters (n = 15) were used as controls.
Cardiomyopathic hamsters presented lower blood pressure, body weight, and plasma Na+, and higher heart weight than normal hamsters. Plasma ANF (1-98) and (99-126) levels and ventricular ANF content were higher in cardiomyopathic hamster than in controls. ANF and frusemide decreased blood pressure, and increased diuresis and natriuresis in normal hamsters. The blood pressure reduction by ANF in cardiomyopathic hamsters was approximately of the same magnitude as in normal hamsters but their renal response was blunted. The blood pressure lowering effect of frusemide was similar in both cardiomyopathic and normal hamsters, but the diuretic and natriuretic responses were greatly reduced in the former. Glomerular ANF receptor density was higher and receptor affinity was lower in cardiomyopathic hamsters than in controls. Noradrenaline precontracted vascular strips from cardiomyopathic hamster were more sensitive to the relaxant effect of ANF than those from controls. No differences in either density or affinity of vascular receptor were observed.
The results suggest that the renal hyporesponsiveness of cardiomyopathic hamsters to ANF is not due to a down regulation of glomerular ANF receptors. The fact that the natriuretic response to frusemide is also blunted suggest the involvement of other factors.
旨在研究实验性心力衰竭时肾小球和血管的心房利钠因子(ANF)受体及其与该肽受体后效应的关系。
研究了肾肾小球和肠系膜动脉膜中的ANF结合位点。分别在完整动物和去甲肾上腺素预收缩的主动脉条中评估了ANF的利钠和舒张作用。还评估了血浆和组织中的ANF水平。
该研究在患有中度心力衰竭的心肌病(UM-X7.1)仓鼠(n = 15)上进行。年龄匹配的金黄叙利亚仓鼠(n = 15)用作对照。
心肌病仓鼠的血压、体重和血浆Na+ 低于正常仓鼠,心脏重量高于正常仓鼠。心肌病仓鼠的血浆ANF(1-98)和(99-126)水平以及心室ANF含量高于对照组。ANF和速尿可降低正常仓鼠的血压,并增加利尿和利钠作用。心肌病仓鼠中ANF降低血压的幅度与正常仓鼠大致相同,但其肾脏反应减弱。速尿在心肌病仓鼠和正常仓鼠中降低血压的作用相似,但前者的利尿和利钠反应大大降低。心肌病仓鼠的肾小球ANF受体密度较高,受体亲和力较低。与对照组相比,心肌病仓鼠去甲肾上腺素预收缩的血管条对ANF的舒张作用更敏感。未观察到血管受体在密度或亲和力上的差异。
结果表明,心肌病仓鼠对ANF的肾脏低反应性并非由于肾小球ANF受体的下调。对速尿的利钠反应也减弱这一事实表明还涉及其他因素。